Beyond Awareness: Experts Warn Of Hidden Genotype Risks Driving Nigeria’s Sickle Cell Crisis
Awareness Without Understanding: A Silent Gap
DESPITE years of public health campaigns urging Nigerians to “know your genotype,” new findings suggest that awareness has not translated into meaningful understanding or informed decision-making.
A recent study revealed that while a vast majority of young Nigerians are aware of their genotype, nearly 90 per cent cannot accurately assess the risk of having a child with sickle cell disorder. This gap between knowledge and comprehension is emerging as a critical factor sustaining Nigeria’s high burden of the disease.
Medical experts argue that genotype awareness has become more of a label than a tool for preventive healthcare, with many individuals lacking a clear grasp of genetic inheritance patterns.
The Complexity of Genetic Risk
Genotype combinations such as AA, AS, SS, AC, and SC determine not only an individual’s health status but also the potential outcomes for future offspring.
However, according to public health specialists, many Nigerians underestimate the risks associated with certain pairings, particularly AS–AS unions, which carry a significant probability of producing children with sickle cell disorder.
Optimism bias further complicates the issue. Many individuals rely on anecdotal examples of couples with similar genotypes who have healthy children, ignoring the statistical risks involved.
Testing Without Counselling: A Systemic Weakness
Experts point to structural gaps in Nigeria’s healthcare system as a major contributor to the problem.
While genotype testing is widely available, it is often conducted without proper genetic counselling. Patients frequently receive results without detailed explanations of their implications for marriage and reproduction.
Additionally, disparities in laboratory standards raise concerns about diagnostic accuracy, particularly in underserved and rural areas.
Healthcare professionals argue that testing without counselling undermines the purpose of genotype awareness, leaving individuals ill-equipped to make informed life decisions.
Overlooked Variants and Misconceptions
Public discourse has largely focused on AA, AS, and SS genotypes, often neglecting other clinically significant variants such as AC and SC.
Experts warn that individuals with SC genotype, commonly perceived as having milder symptoms, can still experience severe complications. Similarly, AS carriers, though often asymptomatic, face reproductive risks when paired with another carrier.
Misunderstandings also persist at a basic level, with some individuals confusing genotype with blood group — a reflection of broader health literacy challenges.
Call for System-Level Reforms
Stakeholders are calling for a shift from individual responsibility to comprehensive system-level interventions.
Recommendations include integrating genotype screening into routine healthcare services, strengthening laboratory quality control, and expanding access to genetic counselling.
Experts also advocate for more targeted and culturally sensitive public health messaging that goes beyond awareness to promote behavioural change.
They stress that tackling Nigeria’s sickle cell burden requires coordinated efforts across healthcare, education, and community systems.
